PropelRx

PropelRx transforms how early-stage founders approach institutional fundraising by shifting focus from investor prospecting to internal readiness. Rather than jumping into outreach with investor databases or CRM tools, founders use PropelRx to evaluate whether their company is structurally prepared for investor conversations. This pre-assessment approach reduces wasted time on premature pitches and increases the likelihood of successful fundraising outcomes. The platform serves Seed through Series B founders who recognize that investor readiness extends beyond a polished pitch deck. PropelRx identifies gaps in capitalization structure, governance, financial documentation, and operational foundations that institutional investors scrutinize during due diligence. By addressing these gaps proactively, founders enter conversations with stronger positioning and fewer obstacles to closing. Unlike traditional fundraising tools that focus on list-building and pipeline management, PropelRx functions as a diagnostic framework. It guides founders through critical assessment areas that determine whether they're truly ready for institutional capital. This structural evaluation accelerates the fundraising timeline by eliminating the back-and-forth delays that occur when investors discover foundational issues during later-stage due diligence.